Literature DB >> 9504983

Complementation of methionine auxotrophs of Pseudomonas aeruginosa from cystic fibrosis.

A L Barth1, N Woodford, T L Pitt.   

Abstract

Auxotrophic Pseudomonas aeruginosa are exclusive to respiratory infections in cystic fibrosis (CF) and bronchiectatic patients, and isolates require specific amino acids for growth on minimal media, particularly methionine. Since auxotrophic and prototrophic P. aeruginosa from CF are identical by genotyping, we investigated the genetic events leading to methionine auxotrophy (Met-). Most (10/13) Met- strains had the same pattern of growth on methionine precursors and required methionine exclusively for growth. Back mutation to prototrophy was very low (frequencies 10(-8) to <10(-10)). Complementation of the mutations leading to auxotrophy was achieved for five strains with a genomic library of P. aeruginosa PAO1. Strains with different patterns of growth on methionine precursors were complemented by clones with different restriction patterns, while identical clones complemented strains with the same pattern of growth on methionine precursors. Methionine auxotrophy in P. aeruginosa from CF results from stable chromosomal mutations, and the commonest defect is probably in gene(s) encoding enzymes that convert homocysteine to methionine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504983     DOI: 10.1007/s002849900292

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  2 in total

1.  Metabolic and genetic basis for auxotrophies in Gram-negative species.

Authors:  Yara Seif; Kumari Sonal Choudhary; Ying Hefner; Amitesh Anand; Laurence Yang; Bernhard O Palsson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-04       Impact factor: 11.205

2.  Nutritional requirement among Pseudomonas aeruginosa isolates recovered from respiratory clinical specimens at a tertiary hospital from South of Brazil.

Authors:  Leandro Reus Rodrigues Perez; Ana Lúcia Peixoto de Freitas; Afonso Luís Barth
Journal:  Braz J Microbiol       Date:  2011-09-01       Impact factor: 2.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.